Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
about
Inhibition of platelet aggregation and thrombosis by indole alkaloids isolated from the edible insect Protaetia brevitarsis seulensis (Kolbe).Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonanceAnticoagulant activities of piperlonguminine in vitro and in vivo.Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivoAntithrombotic and profibrinolytic activities of eckol and dieckol.Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans.Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium.Tissue factor: mechanisms of decryption.Evaluation of novel factor Xa inhibitors from Oxya chinensis sinuosa with anti-platelet aggregation activity.Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.Antiplatelet, anticoagulant, and profibrinolytic activities of cudratricusxanthone A.Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial.Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.Platelet binding and activity of a factor VIIa variant with enhanced tissue factor independent activity.Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.Antithrombotic activities of oroxylin A in vitro and in vivo.Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro.Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa.Antithrombotic activities of epi-sesamin in vitro and in vivo.
P2860
Q33684221-3BDF8DFE-EE1C-42AC-9FD8-C74542A983C7Q33828959-C887D024-918F-412E-8CDA-74E726DCC845Q34049247-626C6E69-DD55-4D43-90B1-EB86CAB52797Q34179874-410AB309-ACA1-49E8-8EB3-EDB7D2DD3037Q34268861-FC4E1A9E-3F61-47FF-9A1B-369B86A40ECCQ34548522-7350305A-9834-49AF-93C6-0CCC5D36808AQ35006603-2053130E-8E8A-44AA-B99E-D93129B8E8AAQ35167279-0C462B32-DAC8-4CE5-AC5D-461E981237E6Q36611360-7B107E61-AE19-4D24-A1C8-40DA2094F954Q36991863-C1391AFA-B7ED-435C-9A54-A9786556B9F6Q37444639-0B2B85B5-5063-429B-8A48-2758A61F18B5Q41366810-FCA12004-8A9D-4E6F-9704-3B6CA6C1EEE0Q42217401-1963BF52-01D8-4D8E-A896-D5CBA4137A68Q43443463-AA843D8D-DEFF-49BB-8271-DCCAA99E0C2BQ43893957-BC03C0F8-3D62-4148-A725-C506408315C4Q44932436-07216B79-728B-4425-B25C-BAB6ADE3905AQ45866827-D004D5DC-0118-4253-8A3A-A7A53FFAAF92Q45879180-B9389F7D-0CF4-4ADF-8F82-E23F24F64973Q46536633-AA6571EC-6408-45A9-A008-9021C09AB944Q50270193-DBFE232C-FC2A-462C-8268-4ADB91437EACQ50447480-9040D22B-2599-4B1F-BA1D-93B2586B01B2Q54603248-B2859842-641A-4F24-90FC-0A607CBA6DF3
P2860
Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Activity and regulation of fac ...... the endothelial cell surface.
@en
type
label
Activity and regulation of fac ...... the endothelial cell surface.
@en
prefLabel
Activity and regulation of fac ...... the endothelial cell surface.
@en
P2093
P1476
Activity and regulation of fac ...... the endothelial cell surface.
@en
P2093
P304
P356
10.1111/J.1538-7836.2007.02308.X
P577
2006-11-09T00:00:00Z